# ArtBio funding rounds and investors

As of 14 Oct 2026, ArtBio has raised $132M across 1 verified round on record; latest: $132 million Series B led by B Capital and Sofinnova Partners, announced 29 Jul 2025.

ARTBIO develops alpha radioligand therapies focused on cancer treatment aimed at healthcare providers and patients.

Website: https://artbio.com  
Page: https://fireround.dev/companies/artbio.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-07-29 | Series B | $132 million | B Capital, Sofinnova Partners | Alexandria Venture Investments, F-Prime Capital, Omega Funds, Qatar Investment Authority (QIA), Third Rock Ventures | [prnewswire.com](https://www.prnewswire.com/news-releases/artbio-announces-132-million-series-b-financing-to-advance-pipeline-of-alpha-radioligand-therapies-and-expand-manufacturing-and-supply-chain-infrastructure-302515362.html) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.